|
A more recent version of this article appeared on March 31, 2006
Papers In Press, published online ahead of print February 2, 2006
J. Biol. Chem, 10.1074/jbc.M511212200
Submitted on October 14, 2005
Accepted on February 2, 2006
Oncostatin M receptor-mediated signal transduction is negatively regulated by suppressor of cytokine signaling (SOCS) 3 through a receptor tyrosine-independent mechanism
Claudia Stross, Simone Radtke, Thomas Clahsen, Christa Gerlach, Rudolf Volkmer-Engert, Fred Schaper, Peter C. Heinrich, and Heike M. Hermanns
Institut für Biochemie, Universitätsklinikum RWTH Aachen, Aachen, NRW 52074
Corresponding Author: hermanns{at}rwth-aachen.de
Downregulation of interleukin (IL)-6-type cytokine signaling has been shown to occur, among other mechanisms, via induction of the feedback inhibitor suppressor of cytokine signaling 3 (SOCS3). Binding of SOCS3 to the phosphorylated Y759 in the cytoplasmic region of gp130, the common signal transducing receptor chain of all IL-6-type cytokines, is necessary for inhibition of Janus kinase (JAK)-mediated signaling. In the present study, we analyzed the effect of SOCS3 on signal transduction by the pro-inflammatory cytokine oncostatin M (OSM), which signals through a receptor complex of gp130 and the OSMR. OSM leads to a much stronger and prolonged induction of SOCS3 in HepG2 hepatoma cells and murine embryonal fibroblasts (MEF) compared to IL-6. A negative effect of SOCS3 on OSM signaling was confirmed using MEF cells lacking SOCS3. We can show that the OSMR-mediated signaling is inhibited by SOCS3 to a similar extent as previously described for gp130. However, the inhibition occurs independent of tyrosine motifs within the OSMR. Instead SOCS3 interacts directly with JAK1 in a stimulation-dependent manner, a mechanism so far only known for SOCS1.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Hintzen, C. Evers, B. E. Lippok, R. Volkmer, P. C. Heinrich, S. Radtke, and H. M. Hermanns
Box 2 Region of the Oncostatin M Receptor Determines Specificity for Recruitment of Janus Kinases and STAT5 Activation
J. Biol. Chem.,
July 11, 2008;
283(28):
19465 - 19477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Dierssen, N. Beraza, H. H. Lutz, C. Liedtke, M. Ernst, H. E. Wasmuth, and C. Trautwein
Molecular Dissection of gp130-dependent Pathways in Hepatocytes during Liver Regeneration
J. Biol. Chem.,
April 11, 2008;
283(15):
9886 - 9895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dambacher, F. Beigel, J. Seiderer, D. Haller, B. Goke, C. J Auernhammer, and S. Brand
Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease
Gut,
September 1, 2007;
56(9):
1257 - 1265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Murray
The JAK-STAT Signaling Pathway: Input and Output Integration
J. Immunol.,
March 1, 2007;
178(5):
2623 - 2629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chattopadhyay, E. Tracy, P. Liang, O. Robledo, S. Rose-John, and H. Baumann
Interleukin-31 and Oncostatin-M Mediate Distinct Signaling Reactions and Response Patterns in Lung Epithelial Cells
J. Biol. Chem.,
February 2, 2007;
282(5):
3014 - 3026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. C. Orth, K. Aktories, and K. F. Kubatzky
Modulation of Host Cell Gene Expression through Activation of STAT Transcription Factors by Pasteurella multocida Toxin
J. Biol. Chem.,
February 2, 2007;
282(5):
3050 - 3057.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|